...will focus on exploiting toll-like receptors (TLRs) to treat various diseases. Organon, Pepscan, Notox, BioDetection, PamGene...
...Leiden, the Netherlands Notox A/S , Herlev, Denmark OctoPlus N.V. (Euronext:OCTO), Leiden, the Netherlands PamGene B.V....

...Invitrogen and PamGene will co-market Invitrogen's nuclear hormone receptor proteins and Lanthascreen assay technology with PamGene's...
...terms were not disclosed. Invitrogen Corp. (NASDAQ:IVGN), Carlsbad, Calif. University of Queensland , Brisbane, Australia PamGene B.V....

...will use PamGene's microarray-based kinase activity profiling and cellular inhibition assays in its research programs. PamGene...

...Newron $24.8 7/23/02 Ph III Nycomed NA NA Mkt Orexo $6.0 8/17/04 Ph II done PamGene...

...and will later offer a service through a spinout company from its Institute of Genetics. PamGene...

...Microarray company PamGene and Jerini Peptide Technology, a division of Jerini, partnered to combine their respective...
...combine their respective kinase technologies to develop a kinase inhibitor screening platform. Under the deal, PamGene...
...PamGene will pay Jerini Peptide fees for peptides plus royalties. Jerini AG , Berlin, Germany PamGene...

...Microarray company PamGene (Den Bosch, the Netherlands) and Jerini Peptide Technology, a division of Jerini (Berlin...
...combine their respective kinase technologies to develop a kinase inhibitor screening platform. Under the deal, PamGene...
...which will contain four microarrays -- for kinase inhibitor compound screening, lead generation and optimization. PamGene...

...INNX licensed exclusive rights from PamGene to its Pamstation 12 instrumentation and microarray technology to develop...
...include oncology diagnostics. INNX expects the first set of assays to be available in 2006. PamGene...
...an upfront payment and is eligible for milestones and royalties. Innogenetics NV (Euronext:INNX), Ghent, Belgium PamGene B.V....

...Innogenetics (Euronext:INNX) licensed exclusive rights from PamGene (Hertogenbosch, the Netherlands) to its Pamstation 12 instrumentation and...
...include oncology diagnostics. INNX expects the first set of assays to be available in 2006. PamGene...